medDARE and Deemea Announce Strategic Partnership to Expand Access to High-Quality Medical Data Across Europe

title
title
title

Accelerating your AI Success

Explore
October 1, 2025 | 6 min read

Paris, France / Bucharest, Romania – [01-Oct-2025]medDARE, a medical data collection and annotation company supporting AI development in healthcare, and Deemea, a leading imaging data processing company, are proud to announce their new strategic partnership. 

This collaboration aims to unlock new data access pathways across Europe and emerging markets by combining Deemea’s vast medical network with medDARE’s deep expertise in medical data annotation for AI and research.

“At Deemea, we’re focused on connecting innovation with real-world healthcare,” said Charlotte Pouchy, CEO of Deemea. “Partnering with medDARE allows us to offer our network to open the door to deeper collaboration in data collection and annotation, clinical validation, and cross-border R&D projects.”

Evgenia Mocanu, CEO of medDARE, added: “This partnership is a natural fit. Deemea’s strong relationships with hospitals will accelerate our ability to bring real, diverse datasets to AI developers around the world. Together, we’re bridging the gap between medical ecosystems and cutting-edge healthcare innovation.”

Both companies see this collaboration as a long-term strategic initiative to advance the role of AI in the healthcare sector. By combining their expertise, they will deliver real-world, diverse, and efficiently annotated datasets that are critical for the development and validation of medical AI solutions. 

The partnership is designed to serve the needs of Fortune 500 companies as well as other leading players in the market, ensuring that high-quality data underpins innovation, regulatory compliance, and clinical adoption. Together, the two organizations will strengthen the global ecosystem by empowering clinical partners and accelerating the responsible integration of AI into healthcare.

About medDARE
medDARE is a Romanian-headquartered company providing GDPR- and HIPAA-compliant data collection and annotation services for AI in healthcare. With access to 3M+ patient studies across Europe and US, and a track record in surgical, imaging, and clinical data collection and annotation projects, medDARE helps AI teams and healthcare companies build trusted, high-performance models. 

Visit https://meddare.ai for more information.

Media Contact:
contact@meddare.ai 

About Deemea
Deemea is a digital health company with expertise in the AI-driven structuring and analysis of medical data. Our specialization in imaging data processing has led us to develop and deploy a collaborative platform for medical data analysis, aimed at expediting biopharmaceutical and medical device clinical studies. Our innovative proprietary technology powers a multi-modal, multi-centric platform that prioritizes the security, privacy, and sovereignty of medical data, as well as the sustainability of healthcare facilities. Deemea empowers data-driven research, ultimately expediting patients’ access to innovative therapies.

Visit https://deemea.com/ for more information.

You may also like:

Want to know how we can accelerate your AI success?

Get a quote